Short interest for CERo Therapeutics Hldgs gives investors a sense of the degree to which investors are betting on the decline of CERo Therapeutics Hldgs's stock. Short interest data is updated every two weeks.

CERo Therapeutics Hldgs Stock (NASDAQ:CERO), Short Interest Report

CERo Therapeutics Hldgs

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ABTS

AKAN

ALLG

AVTX

BDRX

BRZE

CERO

CZOO

DTST

DXYZ

GCTS

GMDA

HKIT

Kintara Therapeutics, Inc. - Common Stock

KTRA

MARA

MLKN

MRNO

MSTR

MTTR

MVLA

NCNA

NKLA

NTRB

OTRK

PMEC

PRST

RDDT

SEZL

SMMT

SOBR

STRO

TNXP

UGRO

XXII

Shares of  Kodiak Sciences Inc.  (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss.

Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Pre-Market Outlook

AQST

BCAN

CMND

ETAO

EZFL

FUFU

GETY

HROW

MGRX

MNTS

MXCT

OBLG

SOPA

TSHA

VERB

WORX

Shares of  Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.&lt;/

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket

ATXI

BALY

BIAF

BILI

BNED

EGOX

ELTK

GRPH

IMRN

ITRN

JFBR

LXEH

LXRX

MEDS

MESO

MNKD

MRAI

MRNA

NBTX

NWTN

PLSE

PSTX

RVSN

SELX

SMCI

STAA

TCBP

VNET

VTYX

Shares of  Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.

Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings, Inc. - Warrants

CERO THERAPEUTICS HOLDINGS INC UNIT 1 CL A & 1/3 WT EXP

Two Federal Reserve presidents, traditionally opposed in their respective stances, seem to agree on at least one matter concerning the future <a href="https://www.benzinga.com/topic/interest-rates">direction of monetary policy</a>.
Austan Goolsbee, President of the Chicago Federal Reserve, leans toward the so-called &#8220;doves.&#8221; Neel Kashkari, President of the Minneapolis Federal Reserve, is often recognized as a &#8220;hawk.&#8221;
Both economists want more data to determine the Fed&#8217;s next steps.
<h3 class="wp-block-heading">Kashkari Believes Policy Is Not Restrictive Enough</h3>
Kashkari, in an appearance on CNBC, pointed out that the Fed has increased 10-year real interest rates by approximately 200 basis points since the period before the pandemic.
&#8220;This is about equivalent to as much tightening as we did in the 1994 timing cycle,&#8221; he said. Despite this substantial tightening, &#8220;we&#8217;re not having as much downward pressure as 200 basis points of tightening would have implied,&#8221; Kashkari added.
Further, he expressed concerns about the current perception of financial conditions.
&#8220;The business community does not feel like financial conditions are tight, that makes me question, maybe we&#8217;re not as restrictive as we would have guessed,&#8221; he added.
Overall, Kashkari states that he feels comfortable in maintaining a wait-and-see mode dependent on upcoming data.
Discussing whether recent inflation surprises could be part of a more structural issue, Kashkari stressed the housing market dynamics. 
Ongoing disruptions in the housing market, especially due to the undersupply of new homes, could lead to higher neutral interest rates.
<h3 class="wp-block-heading">Goolsbee Sticks To The Dual Mandate</h3>
Softening the tone, Goolsbee emphasized the heightened policy restrictiveness, &#8220;the level of that is as high as it&#8217;s been in some time. I feel like we&#8217;re in a restriction.&#8221;
The Chicago Fed President stressed the importance of sticking to the dual mandate, which not only looks at inflation but also at the jobs market. 
When asked about the potential for higher rates in the future, Goolsbee remains cautious.
&#8220;Nothing is never not on the table,&#8221; he said. &#8220;The job of central bankers is to be paranoid about everything.&#8221;
Goolsbee distanced himself from speculative discussions on the neutral interest rate, echoing the teachings of his mentor, Paul Volcker: &#8220;I&#8217;m more old school. Paul Volcker was my mentor. Our job is to act. The market&#8217;s job is to react, and let&#8217;s not get it mixed up.&#8221;
<h3 class="wp-block-heading">Market Reactions</h3>
Treasury yields remained relatively stable following the comments from the two Fed officials. The 10-year yield stayed at 4.5%, marking an increase of 5 basis points for the day.
The stock market also showed little change. 
<ul>
<li>The S&amp;P 500, as reflected by the S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), is marginally up by 0.1%. </li>
<li>The Dow Jones Industrial Average notably rose by 0.3%, aiming for its eighth consecutive session of gains. </li>
<li>Tech stocks saw a slight uptick after starting the day on a flat note.</li>
<li>Consumer staples, as tracked by the Consumer Staples Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>), emerged as the top performer for the day, up 0.5%. </li>
<li>Consumer discretionary lagged, with the Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) down 0.6%.</li>
</ul>
Now Read: <a href="https://www.benzinga.com/markets/equities/24/05/38762249/consumer-sentiment-falls-in-may-inflation-expectations-strongly-exceed-feds-2-goal-they-now-perc">Consumer Sentiment Falls In May, Inflation Expectations Strongly Exceed Fed&#8217;s 2% Goal: &#8216;They Now Perceive Negative Developments&#8217;</a>
Image: Shutterstock

Equities

Macro Economic Events

Macro Notification

Market Summary

Bonds

Treasuries

Econ #s

Economics

Federal Reserve

Select Sector SPDR-Consumer Discretionary

Kashkari Vs. Goolsbee, Hawk Vs. Dove: What's Next For The Fed?

Barclays analyst Jeffrey Bernstein maintains US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) with a Overweight and raises the price target from $60 to $64.

Price Target

Analyst Ratings

USFD

Barclays Maintains Overweight on US Foods Hldg, Raises Price Target to $64

WIIM

HOOD

Robinhood Markets shares are trading lower after the company on Wednesday reported Q1 financial results.

AFRM

Affirm shares are trading lower amid volatility after the company reported Q3 financial results.

<a href="https://www.foxnews.com/politics/biden-under-investigation-after-threat-israels-offensive-aid-playing-political-games">https://www.foxnews.com/politics/biden-under-investigation-after-threat-israels-offensive-aid-playing-political-games</a>
The House Oversight Committee is launching an investigation into the Biden administration over its threats to withhold offensive aid <a href="https://www.foxnews.com/category/world/world-regions/israel">from Israel</a> if it proceeds with a ground invasion of the southern Gaza city of Rafah.
Committee Chairman James Comer, R-Ky., questioned both the decision-making process and the timing of the announcement itself in a letter to President Biden's national security adviser, Jake Sullivan.
He also requested a congressional briefing from the White House National Security Council in addition to communications and other documents related to discussions about pausing any kind of aid to Israel, with a deadline of May 24.
"The Committee is alarmed by the Biden administration's willingness to play political games with U.S. taxpayer-funded assistance going to Israel," Comer wrote in a letter signed by Republicans on the Oversight Committee. "On May 9, 2024, President Biden made public that he would not supply offensive weapons that Israel could use in its offensive on Rafah—the last major Hamas stronghold in Gaza."
"Further reporting indicates that the National Security Council actively chose to withhold this information from the public eye for days, in part so that news of the decision would not be known when President Biden delivered a speech touting support for Israel on Holocaust Remembrance Day. The Committee seeks a briefing, as well as documents and information related to this decision, including any legal justification for withholding essential supplies from Israel in its fight against Hamas terrorists who still have Israeli and American hostages."
Biden made the high-stakes ultimatum to Israel's government in a CNN interview that aired Wednesday night as it prepares for a ground invasion of the southern Gaza city of Rafah. The city is currently home to more than a million Palestinians who left other parts of the Gaza Strip, where Israel has conducted its mission to eradicate the terrorist group Hamas.
Biden said Israel would continue to see U.S. support for its defensive systems, like the Iron Dome, in the CNN interview. He added, however, that "if they go into Rafah, I'm not supplying the weapons that have been used historically to deal with Rafah, to deal with the cities, that deal with that problem."
"The Committee finds both the decision to withhold essential military aid and hiding that decision from the public for political purposes disturbing, especially given that on President Biden's first day in office, White House Press Secretary Jen Psaki pledged that the administration would, ‘bring transparency and truth back to government.' Hiding information from the public for political gain does not meet this Committee's definition of transparency," Comer wrote.
"The <a href="https://www.foxnews.com/politics/no-choice-impeach-biden-delayed-israel-aid-gop-senator-says">Biden administration's</a> priorities appear to be motivated by public perception, and not what is best for national security or diplomacy."
Fox News Digital reached out to the White House for comment.
<a href="https://www.foxnews.com/media/bidens-hold-israel-weapons-shipment-stuns-retired-us-general-turning-point">BIDEN'S HOLD ON ISRAEL WEAPONS SHIPMENT STUNS RETIRED US GENERAL: ‘THIS IS A TURNING POINT'</a>
White House National Security Communications Advisor&nbsp;John Kirby suggested to reporters on Thursday that Israel was aware of the Biden administration's warning about offensive aid before his CNN interview and stressed that Israel has yet to wage a full invasion of Rafah's population centers.
"The President said yesterday that if Israel in fact proceeds with a major ground operation in Rafah, he will not provide certain categories of weapons to support such an operation.&nbsp; The Israeli government has understood this for some time," Kirby said.
<a href="https://www.foxnews.com/apps-products?pid=AppArticleLink">CLICK HERE TO GET THE FOX NEWS APP</a>&nbsp;
"He also said yesterday that he will continue to ensure that Israel has all of the military means it needs to defend itself against all of its enemies, including Hamas.&nbsp; For him, this is straightforward:&nbsp;He will continue to provide Israel with all of capabilities it needs, but he does not want certain categories of American weapons used in a particular type of operation in a particular place. And again, he has been clear and consistent with that."
Notably, however, Biden said of Israel aid in a 2019 PBS interview, "The idea that we would cut off military aid to an ally, our only true, true ally in the entire region, is absolutely preposterous. It's just beyond my comprehension anyone would do that."
The House Oversight Committee has already been investigating the Biden administration's funding to the United Nations Relief and Works Agency (UNRWA), after staffers for the refugee organization were accused of links to the October 7, 2023, Hamas terror attack in southern Israel.

Global

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

"President Biden Under Investigation After Threat To Israel's Offensive Aid: 'Playing Political Games'; House Oversight Committee Chair James Comer Is Leading The Effort" - Fox News

Barclays analyst Ross Sandler maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Equal-Weight and lowers the price target from $28 to $27.

Barclays Maintains Equal-Weight on Unity Software, Lowers Price Target to $27

God of War: Ragnarok, the highly acclaimed Sony Group Corp.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) PlayStation exclusive, is reportedly poised to <a href="https://www.benzinga.com/general/gaming/24/03/37793995/sonys-playstation-5-pro-specs-leaked-online-everything-you-need-to-know">launch on PC. </a>
A leaker, who <a href="https://www.dealabs.com/magazine/lexclusivite-playstation-god-of-war-ragnarok-sortira-bientot-sur-pc-50164">writes</a> for Dealabs as Billbil-kun, suggested that an official announcement is expected in May, though no specific release date was provided.
See Also: <a href="https://www.benzinga.com/general/gaming/24/02/37132427/sony-ps5-enters-latter-stage-of-its-life-cycle-major-franchise-titles-on-hold-until-2025">Sony PS5 Enters Latter Stage Of Its Life Cycle, Major Franchise Titles On Hold Until 2025</a>
God of War: Ragnarok initially debuted on PlayStation 4 and 5 in November 2022, quickly becoming a record-breaking success, with over 15 million copies sold as of November 2023.
This move follows Sony&#8217;s trend of bringing its popular titles to the PC platform, as seen with games like Horizon Forbidden West, Ratchet &amp; Clank: Rift Apart, and The Last of Us Part 1. Ghost of Tsushima is also set to arrive on PC soon. 
While Sony has been expanding its reach to PC players, it has refrained from simultaneous releases with console launches, although there have been <a href="https://www.benzinga.com/general/gaming/24/02/37015019/this-game-outperformed-call-of-duty-and-palworld-on-steam-a-look-at-sonys-first-simultaneous-ps5-a">exceptions like Helldivers 2.</a>
<a href="https://www.ign.com/articles/god-of-war-ragnarok-reportedly-the-next-playstation-exclusive-to-hit-pc">According</a> to IGN, Sony might address these rumors in an upcoming State of Play broadcast. If God of War: Ragnarok indeed arrives on PC, it will mark another significant step in Sony&#8217;s efforts to reach a broader audience beyond its PlayStation consoles.
Read Next: <a href="https://www.benzinga.com/general/gaming/24/03/37630216/exclusivity-is-your-achilles-heel-beyond-200m-budget-warns-former-playstation-exec">Exclusivity Is Your Achilles&#8217; Heel Beyond $200M Budget, Warns Former PlayStation Exec</a>
Image credits: <a href="https://www.shutterstock.com/es/g/miglagoa">Miguel Lagoa</a> on Shutterstock.

Gaming

Sony Group Corporation American Depositary Shares

SONY

PlayStation Exclusive God Of War: Ragnarok Reportedly Set For PC Release

Oil is trading lower in potential reaction to low US consumer sentiment, which could impact demand outlook.

Barclays analyst Matthew Bouley maintains Trex Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) with a Underweight and raises the price target from $93 to $94.

TREX

Barclays Maintains Underweight on Trex Co, Raises Price Target to $94

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNX#NASDAQ">CRNX</a>) with a Buy and maintains $60 price target.

Reiteration

CRNX

HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $60 Price Target

HC Wainwright &amp; Co. analyst Patrick Trucchio maintains Mind Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNMD#NASDAQ">MNMD</a>) with a Buy and lowers the price target from $75 to $35.

MNMD

HC Wainwright & Co. Maintains Buy on Mind Medicine, Lowers Price Target to $35

Barclays analyst Ross Sandler maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Equal-Weight and lowers the price target from $46 to $35.

RBLX

Barclays Maintains Equal-Weight on Roblox, Lowers Price Target to $35

HC Wainwright &amp; Co. analyst Douglas Tsao maintains Coherus BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRS#NASDAQ">CHRS</a>) with a Buy and raises the price target from $11 to $12.

CHRS

HC Wainwright & Co. Maintains Buy on Coherus BioSciences, Raises Price Target to $12

XPOF

Xponential Fitness shares are trading lower after the company announced it relieved CEO Anthony Geisler from his duties and suspended him indefinitely. Also, the company announced that it intends to cooperate with the investigation by the USAO for the Central District of California and the SEC.

Barclays analyst Lauren Lieberman maintains Reynolds Consumer Prods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REYN#NASDAQ">REYN</a>) with a Equal-Weight and raises the price target from $28 to $29.

REYN

Barclays Maintains Equal-Weight on Reynolds Consumer Prods, Raises Price Target to $29

Barclays analyst Brandt Montour maintains Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) with a Equal-Weight and raises the price target from $153 to $159.

Barclays Maintains Equal-Weight on Hyatt Hotels, Raises Price Target to $159

WonderFi Technologies Inc. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/WNDR#TSX">WNDR</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/WONDF#OTCQB">WONDF</a>), a regulated cryptocurrency trading and digital asset management company, defied the odds this week, kicking off its year with robust financial results. The company reported a revenue increase of 43.4% to $18.5 million and a net income of $4.9 million, a recovery from the prior quarter's loss.
Here's Why It Matters: WonderFi&#8217;s turnaround highlights its success in leveraging synergies from recent acquisitions and refining operations to enhance cost management. With an EBITDA of $7.0 million, representing 37.8% of consolidated revenues, the company has translated robust top-line growth into substantial earnings.
The firm&#8217;s cash and digital assets have surged to $52.5 million, up from $37.3 million at the end of 2023, with trading volumes at a record $1.1 billion. Its platforms Bitbuy and Coinsquare also hold over $1.6 billion in client assets under custody. 
In 2023, investor Kevin O'Leary expressed his bullish outlook for the company, <a href="https://www.benzinga.com/markets/cryptocurrency/23/04/31660952/exclusive-kevin-oleary-says-hes-much-wiser-post-ftx-praises-diversification-and-wonderfis-">noting</a>, "If you don't have scale, I don't think you'll survive because you won't afford the compliance cost."
What To Watch For Next: WonderFi&#8217;s commitment to regulation and transparency has positioned it as a pillar of stability and innovation, particularly following the volatility that led to the downfall of some bigger peers over the past three years.
Dean Skurka, WonderFi&#8217;s President and CEO, said the company's impressive results are "a reflection of Management&#8217;s strategic direction and the foundation established in fiscal 2023—our breakout year, highlighted by transformative acquisitions, improved financial results and sequential growth across our operating platforms."
Now Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38767405/marathon-digital-ramps-up-mining-capacity-is-a-turnaround-in-the-making">Marathon Digital Ramps Up Mining Capacity &#8211; Is A Turnaround in the Making?</a>
Photo: WonderFi

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

TSX:WNDR

WONDF

Kevin O'Leary-Backed WonderFi Celebrates Strong Revenue Growth, Financial Turnaround

HC Wainwright &amp; Co. analyst Douglas Tsao maintains argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) with a Buy and lowers the price target from $451 to $448.

ARGX

HC Wainwright & Co. Maintains Buy on argenx, Lowers Price Target to $448

Xponential Fitness Shares Resume Trading

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Disc Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRON#NASDAQ">IRON</a>) with a Buy and maintains $70 price target.

IRON

HC Wainwright & Co. Reiterates Buy on Disc Medicine, Maintains $70 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a great way to start the week as we check out all of the biggest trades happening on Monday morning!



Moving stocks are Board changes, a special dividend, one company&rsquo;s going concern and more.



Let&rsquo;s get into this news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Kidpik (NASDAQ:<a href="https://investorplace.com/stock-quotes/pik-stock-quote/">PIK</a>) stock is rocketing more than 270% alongside heavy pre-market trading.</li>



<li>Fangdd Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/duo-stock-quote/">DUO</a>) shares are soaring close to 105% as it plans to enter the <a href="https://www.nasdaq.com/press-release/fangdd-unveils-2024-strategic-layout-aims-to-enter-the-real-estate-stock-asset">real estate stock asset services sector</a>.</li>



<li>Auddia (NASDAQ:<a href="https://investorplace.com/stock-quotes/auud-stock-quote/">AUUD</a>) stock is surging over 54% with strong early morning trading.</li>



<li>HeartCore Enterprises (NASDAQ:<a href="https://investorplace.com/stock-quotes/htcr-stock-quote/">HTCR</a>) shares are gaining more than 34% despite a lack of news this morning.</li>



<li>Mesoblast (NASDAQ:<a href="https://investorplace.com/stock-quotes/meso-stock-quote/">MESO</a>) stock is increasing by almost 21% <a href="https://www.nasdaq.com/market-activity/stocks/meso/press-releases">following an update</a> from the Food and Drug Administration (FDA).</li>



<li>AirNet Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ante-stock-quote/">ANTE</a>) shares are heading 20% higher <a href="https://www.nasdaq.com/press-release/airnet-announces-changes-in-the-board-of-directors-2024-03-11">after announcing changes</a> to its board of directors.</li>



<li>Graphite Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/grph-stock-quote/">GRPH</a>) stock is rising over 18% higher after announcing a <a href="https://www.nasdaq.com/press-release/graphite-bio-declares-special-dividend-in-connection-with-proposed-merger-with-lenz">special dividend tied to a merger</a>.</li>



<li>GDS Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/gds-stock-quote/">GDS</a>) shares are jumping more than 18% on reports of <a href="https://www.bloomberg.com/news/articles/2024-03-11/hillhouse-boyu-and-cdh-said-to-eye-stake-in-gds-s-se-asia-data-centers">potential new investments in the company</a>.</li>



<li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is climbing nearly 17% with heavy trading today.</li>



<li>NuScale Power (NYSE:<a href="https://investorplace.com/stock-quotes/smr-stock-quote/">SMR</a>) shares are up over 14% after <a href="https://www.nasdaq.com/press-release/nuscale-power-to-participate-in-march-and-april-2024-investor-conferences-2024-03-11">announcing investor conferences</a>.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>Semilux International (NASDAQ:<a href="https://investorplace.com/stock-quotes/selx-stock-quote/">SELX</a>) stock is diving more than 22% following a Friday rally.</li>



<li>DHC Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/dhca-stock-quote/">DHCA</a>) shares are tumbling over 21% as it <a href="https://www.nasdaq.com/press-release/dhc-acquisition-corp.-shareholders-approve-previously-announced-business-combination">closes in on a merger</a>.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) stock is taking a close to 19% beating as it <a href="https://investorplace.com/2024/03/why-is-psyence-biomedical-pbm-stock-up-90-today/">comes off a recent rally</a>.</li>



<li>Lytus Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyt-stock-quote/">LYT</a>) shares are sliding more than 17% <a href="https://www.nasdaq.com/press-release/lytus-technologies-and-mobilicom-interviews-to-air-on-the-redchip-small-stocks-big">following recent interviews</a>.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) stock is dropping over 16% despite a lack of news this morning.</li>



<li>Avenue Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/atxi-stock-quote/">ATXI</a>) shares are decreasing more than 16% as it <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318147286&amp;type=PDF&amp;symbol=ATXI&amp;cdn=c287b872a448ad953fb1e7caef733ef4&amp;companyName=Avenue+Therapeutics+Inc.&amp;formType=PRE+14C&amp;formDescription=Other+preliminary+information+statements&amp;dateFiled=2024-03-08">plans for a reverse stock split</a>.</li>



<li>CERo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) stock is declining over 15% after jumping in price on Friday.</li>



<li>Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) shares are slipping more than 15% <a href="https://investorplace.com/2024/03/why-is-mira-pharmaceuticals-mira-stock-up-52-today/">after a recent rally</a>.</li>



<li>Barnes &amp; Noble Education (NYSE:<a href="https://investorplace.com/stock-quotes/bned-stock-quote/">BNED</a>) stock is dipping almost 15% after raising <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318147361&amp;type=PDF&amp;symbol=BNED&amp;cdn=18e126e053d1e7db9202a65954d363c6&amp;companyName=Barnes+%26+Noble+Education+Inc&amp;formType=NT+10-Q&amp;formDescription=Notification+of+inability+to+timely+file+Form+10-Q+or+10-QSB&amp;dateFiled=2024-03-08">doubts about its ability to continue</a> as a going concern.</li>



<li>XBP Europe (NASDAQ:<a href="https://investorplace.com/stock-quotes/xbp-stock-quote/">XBP</a>) shares close out our pre-market stock movers down over 14%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-march-5th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a great way to start the week as we check out all of the biggest trades happening on Monday morning!



Moving stocks are Board changes, a special dividend, one company&rsquo;s going concern and more.



Let&rsquo;s get into this news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Kidpik (NASDAQ:<a href="https://investorplace.com/stock-quotes/pik-stock-quote/">PIK</a>) stock is rocketing more than 270% alongside heavy pre-market trading.</li>



<li>Fangdd Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/duo-stock-quote/">DUO</a>) shares are soaring close to 105% as it plans to enter the <a href="https://www.nasdaq.com/press-release/fangdd-unveils-2024-strategic-layout-aims-to-enter-the-real-estate-stock-asset">real estate stock asset services sector</a>.</li>



<li>Auddia (NASDAQ:<a href="https://investorplace.com/stock-quotes/auud-stock-quote/">AUUD</a>) stock is surging over 54% with strong early morning trading.</li>



<li>HeartCore Enterprises (NASDAQ:<a href="https://investorplace.com/stock-quotes/htcr-stock-quote/">HTCR</a>) shares are gaining more than 34% despite a lack of news this morning.</li>



<li>Mesoblast (NASDAQ:<a href="https://investorplace.com/stock-quotes/meso-stock-quote/">MESO</a>) stock is increasing by almost 21% <a href="https://www.nasdaq.com/market-activity/stocks/meso/press-releases">following an update</a> from the Food and Drug Administration (FDA).</li>



<li>AirNet Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/ante-stock-quote/">ANTE</a>) shares are heading 20% higher <a href="https://www.nasdaq.com/press-release/airnet-announces-changes-in-the-board-of-directors-2024-03-11">after announcing changes</a> to its board of directors.</li>



<li>Graphite Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/grph-stock-quote/">GRPH</a>) stock is rising over 18% higher after announcing a <a href="https://www.nasdaq.com/press-release/graphite-bio-declares-special-dividend-in-connection-with-proposed-merger-with-lenz">special dividend tied to a merger</a>.</li>



<li>GDS Holdings (NASDAQ:<a href="https://investorplace.com/stock-quotes/gds-stock-quote/">GDS</a>) shares are jumping more than 18% on reports of <a href="https://www.bloomberg.com/news/articles/2024-03-11/hillhouse-boyu-and-cdh-said-to-eye-stake-in-gds-s-se-asia-data-centers">potential new investments in the company</a>.</li>



<li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is climbing nearly 17% with heavy trading today.</li>



<li>NuScale Power (NYSE:<a href="https://investorplace.com/stock-quotes/smr-stock-quote/">SMR</a>) shares are up over 14% after <a href="https://www.nasdaq.com/press-release/nuscale-power-to-participate-in-march-and-april-2024-investor-conferences-2024-03-11">announcing investor conferences</a>.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>Semilux International (NASDAQ:<a href="https://investorplace.com/stock-quotes/selx-stock-quote/">SELX</a>) stock is diving more than 22% following a Friday rally.</li>



<li>DHC Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/dhca-stock-quote/">DHCA</a>) shares are tumbling over 21% as it <a href="https://www.nasdaq.com/press-release/dhc-acquisition-corp.-shareholders-approve-previously-announced-business-combination">closes in on a merger</a>.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) stock is taking a close to 19% beating as it <a href="https://investorplace.com/2024/03/why-is-psyence-biomedical-pbm-stock-up-90-today/">comes off a recent rally</a>.</li>



<li>Lytus Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lyt-stock-quote/">LYT</a>) shares are sliding more than 17% <a href="https://www.nasdaq.com/press-release/lytus-technologies-and-mobilicom-interviews-to-air-on-the-redchip-small-stocks-big">following recent interviews</a>.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) stock is dropping over 16% despite a lack of news this morning.</li>



<li>Avenue Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/atxi-stock-quote/">ATXI</a>) shares are decreasing more than 16% as it <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318147286&amp;type=PDF&amp;symbol=ATXI&amp;cdn=c287b872a448ad953fb1e7caef733ef4&amp;companyName=Avenue+Therapeutics+Inc.&amp;formType=PRE+14C&amp;formDescription=Other+preliminary+information+statements&amp;dateFiled=2024-03-08">plans for a reverse stock split</a>.</li>



<li>CERo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) stock is declining over 15% after jumping in price on Friday.</li>



<li>Mira Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mira-stock-quote/">MIRA</a>) shares are slipping more than 15% <a href="https://investorplace.com/2024/03/why-is-mira-pharmaceuticals-mira-stock-up-52-today/">after a recent rally</a>.</li>



<li>Barnes &amp; Noble Education (NYSE:<a href="https://investorplace.com/stock-quotes/bned-stock-quote/">BNED</a>) stock is dipping almost 15% after raising <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318147361&amp;type=PDF&amp;symbol=BNED&amp;cdn=18e126e053d1e7db9202a65954d363c6&amp;companyName=Barnes+%26+Noble+Education+Inc&amp;formType=NT+10-Q&amp;formDescription=Notification+of+inability+to+timely+file+Form+10-Q+or+10-QSB&amp;dateFiled=2024-03-08">doubts about its ability to continue</a> as a going concern.</li>



<li>XBP Europe (NASDAQ:<a href="https://investorplace.com/stock-quotes/xbp-stock-quote/">XBP</a>) shares close out our pre-market stock movers down over 14%.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-march-5th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

RNLX, ASLN and SONN among pre-market losers

AVLX,  SGH and ETNB are among pre market losers

KOD, ALLG and SST among mid-day movers

NVCR, SBNY and VITL are among after hour movers

CERo Therapeutics files to sell 26.62M shares of common stock

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!



Moving stocks this morning are earnings reports, shareholder meetings, public offerings and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Tian Ruixiang (NASDAQ:<a href="https://investorplace.com/stock-quotes/tirx-stock-quote/">TIRX</a>) stock is rocketing more than 151% after announcing plans for an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318240834&amp;type=PDF&amp;symbol=TIRX&amp;cdn=28383035430ee99a000270a0a49b5cf7&amp;companyName=TIAN+RUIXIANG+Holdings+Ltd&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-17">extraordinary general shareholders meeting</a>.</li>



<li>MicroCloud Hologram (NASDAQ:<a href="https://investorplace.com/stock-quotes/holo-stock-quote/">HOLO</a>) shares are soaring over 52% alongside heavy pre-market trading.</li>



<li>Secoo (NASDAQ:<a href="https://investorplace.com/stock-quotes/seco-stock-quote/">SECO</a>) stock is surging more than 32% with strong early morning trading.</li>



<li>Smart for Life (NASDAQ:<a href="https://investorplace.com/stock-quotes/smfl-stock-quote/">SMFL</a>) shares are rising over 23% after announcing it will <a href="https://www.nasdaq.com/press-release/smart-for-life-to-sponsor-industry-event-whats-up-with-supps-at-supplyside-east-2024">sponsor an upcoming event</a>.</li>



<li>Tenax Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tenx-stock-quote/">TENX</a>) stock is gaining 17% on Thursday morning.</li>



<li>Earlyworks (NASDAQ:<a href="https://investorplace.com/stock-quotes/elws-stock-quote/">ELWS</a>) shares are increasing more than 16% despite a lack of news this morning.</li>



<li>Citius Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/ctxr-stock-quote/">CTXR</a>) stock is climbing over 16% without any apparent news on Thursday.</li>



<li>ReTo Eco-Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/reto-stock-quote/">RETO</a>) shares are heading more than 15% higher this morning.</li>



<li>CERo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) stock is jumping over 14% with no obvious news to report.</li>



<li>Bruush Oral Care (NASDAQ:<a href="https://investorplace.com/stock-quotes/brsh-stock-quote/">BRSH</a>) shares are up more than 13% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Semilux International (NASDAQ:<a href="https://investorplace.com/stock-quotes/selx-stock-quote/">SELX</a>) stock is crashing over 43% with no obvious news this morning.</li>



<li>Canaan (NASDAQ:<a href="https://investorplace.com/stock-quotes/can-stock-quote/">CAN</a>) shares are plummeting more than 28% after releasing its <a href="https://www.nasdaq.com/press-release/canaan-inc.-files-2023-annual-report-on-form-20-f-2024-04-17">2023 annual report</a>.</li>



<li>NRX Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrxp-stock-quote/">NRXP</a>) stock is diving over 24% on a <a href="https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-announces-proposed-underwritten-public-offering-of-common-stock-302120123.html">proposed public offering</a>.</li>



<li>Trilogy Metals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tmq-stock-quote/">TMQ</a>) shares are tumbling more than 22% on an <a href="https://investorplace.com/2024/04/why-is-trilogy-metals-tmq-stock-down-29-today/">Ambler Access Project update</a>.</li>



<li>Lithium Americas (NYSE:<a href="https://investorplace.com/stock-quotes/laac-stock-quote/">LAAC</a>) stock is taking an over 20% beating on <a href="https://seekingalpha.com/news/4090749-lithium-americas-sinks-on-plans-for-55m-share-offering?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">plans for a share offering</a>.</li>



<li>Soligenix (NASDAQ:<a href="https://investorplace.com/stock-quotes/sngx-stock-quote/">SNGX</a>) shares are falling more than 20% <a href="https://investorplace.com/2024/04/why-is-soligenix-sngx-stock-up-58-today/">following a recent rally</a>.</li>



<li>Reliance Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/reli-stock-quote/">RELI</a>) stock is dropping over 19% on Thursday morning.</li>



<li>Trio Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tpet-stock-quote/">TPET</a>) shares are decreasing close to 17% as it <a href="https://investorplace.com/2024/04/why-is-trio-petroleum-tpet-stock-down-22-today/">continues recent negative movement</a>.</li>



<li>iLearningEngines (NASDAQ:<a href="https://investorplace.com/stock-quotes/aile-stock-quote/">AILE</a>) stock is declining 15% today.</li>



<li>SeaStar Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/icu-stock-quote/">ICU</a>) shares close out our pre-market stock movers down more than 14% with the release of its <a href="https://www.nasdaq.com/press-release/seastar-medical-reports-2023-financial-results-and-provides-a-business-update-2024-04">2023 financial results</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CERo Therapeutics Hldgs Stock (NASDAQ:CERO), Short Interest Report

People Also Watch